Republic of Iraq Ministry of Higher Education And scientific research Asoul Aldeen unviersity collage Deparment of dentistry Filler and botox in gummy smile The project is submitted to the Faculty of Dentistry at the Faculty of Fundamentals of Asoul Aldin University, in par-tial implementation of the Bachelor of Dentistry program By: Mohammed khder abbas Tamam Ali Mutab Hawraa waleed AbdulWahid Maryam kassim hashim Supervisor Msc Dr. Tariq Nassif 1444ــھ 2023 م Dedication This thesis is dedicated to the people who have supported me throughout my education. Thanks for making me see this adventure through to the end. I dedicate this project to my family who told me to always keep their head up Acknowledgment First of all we thank God for the most mercy for enabling us to present this project in the best form that we wanted to be, we thank our faculty and doctors that provided us with all the knowledge. Most of all we are all thankful for our families for their endless love, assistance, support and encouragement. And for our friends for their understanding and support for us to complete this project. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Stages in the genesis of a full smile Different muscles involved during a maximum smile. Smile type. Classification of altered passive eruption (APE)¹4. Smile dynamic shows how the gingival smile becomes evident. Intra-oral pictures show health of soft and hard tissue. Incisions with a 15 C blade. After removing the collar of 'excessive' gingiva. Once even the left side of the mouth streated, the natural enamel wonderfully reflects light. A full thickness flap is elevated to confirm the x-ray diagnosis. This problem requires bone resective surgery in order to remove the buccal excess bone, and to create a biologic width for soft tissue attachment. Once resorbable sutures are placed. The new smile is clearly a big improvement. One year follow-up shows perfect stability and adaptation. The gummy smile long gone and a new bright smile has now taken its place. 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 The history of this case showing the dramatic improvement with a very simple surgical procedure. Vertical maxillary excess. Bimaxillary protrusion. Gingival hyperplasia in acute leukaemia patient. Clinical appearance of drug- influenced gingival enlargement at the anterior dentition. Gingival changes in a patient on oral contraceptives. Overgrown gums during braces and orthodontic treatment. Preoperative smile line showing short upper lip and excessive display of gums The lip repositioning surgery as originally described in the dental literature. Non surgical procedure Mercado-rosso gummy smile classification - Overview of the therapeutic strategies according to the Mercado-Rosso gummy smile classification system Treatment strategy of gummy smile type 1 Treatment strategy of gummy smile type 2 Patient with gummy smile type 3 Bage number Chapter name 1 Introduction. 3 Anatomy. 6 Classification of gummy smile. 7 Diagnosis of gummy smile (GM). 8 Etiologies of gummy smile . 14 Bony maxillary excess . 17 Conditions causing gingival enlargement. 21 Treatment of gummy smile. 37 Mercado-Ross classification of gummy smile. Filler and Botox in gummy smile Abstract From a periodontal point of view, various factors contribute to facial aesthetics. In the recent past, studies have revealed that excessive gingival display is a factor that influ-ences an individual’ smile line. Some literature exists to support that more than excessive gingival display of more than 3mm is considered unaesthetic and termed a ‘gummy smile’ (GS). 5 The prevalence of gummy smile’ has been 10% and to be more common in females. Gingi-val hyperplasia altered passive eruption, vertical maxillary excess, and upperlip hyper-mobility can all result in excessive gingival display when a patient smile. To select the correct treatment protocol, accurate diagnosis is essential. Various tech-niques have used to treat gummy smile which includes surgical and nonsurgical methods. Recently nonsurgical method using Botulinum toxin gained polarity considering that the method is minimally invasive. 6 Introduction A patient’s smile can express a sense of joy, success, sensuality, af-fection, courtesy, and show confidence and kindness. Smile is more than a form of communication; it i. kind of socialization and at-traction. Dentistry is undoubtedly the health profession that deals most with smile enhancements. However, dental professionals often overlook key considerations precisely in their planning regarding smile patterns.As suggested, part of the smile esthetics is subjec-tive, but most is objective evaluation. The media offer a stereo-typed picture of the smile that leads to smile standardization and consequently, an increased patients’ demand for cosmetic dentistry. Differently from what some dentists consider, smile harmony is de-termined not only by the shape, position and color of teeth, but also by the gingival tissue. The gingival margin should be as smooth as dental criteria alone. Today, both patients and dentists should be more aware of the impact of gingival upon the beauty of the person’s smile.Periodontium visibility depends on the position of the smile line, which is defined as the ratio between the upper lip and visibility of the gingival tissue and teeth. Smile level is an imaginary line that follows the lower margin of the upper lip and usually has a convex appearance. Excessive exposure of the peri-odontium characterizes the so-called gingival or gummy smile.It should be emphasized that the current aesthetic standards estab-lish a dimorphism concept influenced by age and gender. Thus, a healthy and continuous gingival margin display of around 3 mm during natural smile is desirable for women; for men, only the an-terior teeth display is expected, without the continuous band of gingiva. Age influence is due to the loss of muscle tone, with a con- 7 sequent lower visibility of the upper teeth and a tendency to in-crease lower teeth display.[1,2] The first step in establishing a correct diagnosis is to properly classify the gingival level, taking into consideration variables such as gender, age and periodontal health. The literature, although, abundant in this respect, is not clear and uniform; the authors present different ways of classifying the same thing.[3-5] once the abnormality in the smile level is determined, the establishment of the gummy smile etiology is essential. Generally, it is multifactorial interacting and is related to excessive vertical growth of maxilla, reduced length of the upper lip, excessive contraction of the upper lip and disproportionate crown length and width of anterior teeth, usually, associated with excessive gingival display, and hyperpla-sia or passive eruption.[6-8] upper teeth extrusion, associated with deep bite, can also be related to the problem.[9,10] It is precisely the etiology of gummy smile associated with its classification that will establish a correct diagnosis, upon which all kinds of treatment will be based. In other words, the various types of treatment and their multidisciplinary nature are respected, having, however, just a single one diagnosis. Thus, this literature review seeks to establish the diagnosis, etiology and treatment al-ternatives available to correct gummy smile. Review 8 The smile is a common human expression that reflects different feelings[11] . The smile is an important aesthetic component of the face and significantly impact on the perception of beauty and personality that the others have about us. Additionally, asymmetries in our face or expressions, as well as face proportions, also play an important role in the perception of beauty . [12,13] Gingival display during smile, that is, the exposure of the gingival tissues surrounding the maxillary anterior teeth when smiling, is common. Studies report that 14% to 70% of females [14-19] and 7% to 38% of males present with gingival display, [14-19] that is, they have a high smile. Females are, on average, twice as likely as males to have a high smile, regard-less of age or ethnic origin. [14-21] . Intrinsically, gingival dis-play is an acceptable component of a pleasing smile; however, smile attractiveness typically decreases when gingival display exceeds 2 to 3 mm, which is termed excessive gingival display. [22-26] Excessive gingival display, often referred to as gummy smile, is a condition resulting from diverse causes and is often multifac- torial Anatomy Muscles responsible for upper lip movement during smile are: 9 1. Levator labii superioris(LLS) 2. Levator labii superioris alaeque nasii(LLSAN) 3. Zygomaticus major 4. Zygomaticus minor 5. Depressor septii Mimetic facial muscles (MFM) have various features that differentiate them from other skeletal muscles. The first one is the lack of any tendinous or aponeurotic intermediaries [27]. MFM are, indeed, directly attached at each end and generally originate from underlying bone surfaces and insert to the skin of the face or intermingle with other facial muscles . [28] Upper lip muscles include the zygomaticus major and minor, the levator labii superioris (LLS), the levator labii superioris alaeque nasi (LLSAN), as well as the levator anguli oris (LAO) [29,30] . Different levator muscles pull the upper lip and the corner of the mouth upwards, while the zygomatic muscles have a diagonal action [29,30 ] . The lip muscles can be divided in dilator and constrictor muscles [31] . Dilator muscles are, in turn, distributed into two layers, namely superficial and deep. The superficial layer contains seven muscles: LLSAN, LLS, zygomaticus major and minor, risorius, depressor anguli oris (DAO), and platysma[31] . The characteristics of the smile are determined by the interaction of the static and dynamic relationships between the dento-skeletal and soft tissue components of the face. The smile is formed in two stages (Fig. 1). 10 During the first stage, the contraction of the levator muscles raises the upper lip to the nasolabial fold. The second stage involved further raising superiorly of the lip and the fold by three muscle groups: (1) the levator labii superior muscles of the upper lip, originating at the infraorbital region; (2) the zygomaticus major muscles; and (3) superior fibers of the buccinator (Fig. 2) Although showing a certain amount of gum (1 mm–2 mm) during a normal mile is aesthetically acceptable and in many cases imparts a youthful appearance [ 33-35] , excessive gin- 11 gival visualization during the smile has been an aesthetic problem for many patients, which can defi- nitely affect their psychosocial behavior [36] . Perception of excessive gingival display is also subject to cultural and ethnic preferences. The quantity of gingival showed that is considered unaesthetic, or excessive, is highly subjective, and varies between males and females [37, 38 ] ,and between professionals and laypeo-ple [39,40] . For example, in some European countries gingi-val display of up to 4 mm or more is acceptable, while expo-sure greater than 2–3 mm is considered unsightly in the USA [41]. Gummy smile has been defined as a nonpathological condition causing esthetic disharmony in which more than 3 mm of gingival tissue is exposed when smiling [33, 42] . The GS constitutes a prevalent condition that occurs in 10.5%– 29% [42, 43] of young adults, with the prevalence being high-er in women . [33] Classification of gummy smile The smile can be classified according to different parameters (Table 1). For example, depending on the lips raising direction and the muscle group involved in the smile, it is classified into three categories: The cuspid smile, the complex smile, and the commissure smile or Mona Lisa smile 12 Figure 3: [32, 44, 45] Diagnosis of gummy smile (GM) : Correct diagnosis of GM is done by identifying the etiology with the help of medical and dental history that provide patient age and eruption stage of dentition along with contributing factors for GM. Followed by periodontal examination to measure width of attached gingiva, probing pocket depth and clinical attachment loss to rule out any pathologic and nonpathological changes in the architecture of the periodontium. Later analysis of face done to evaluate vertical maxillary excess (VME) by cephalometric analysis. Lip analysis done both in static and dynamic posture to assess lip length, hypermobility, or both. Dentialveolar analysis is done to measure the interlabial gap by analyzing 3D position of the incisors during rest position. 0-4mm is considered normal interlabial gap.[46,47] Clinical Diagnosis The clinical examination should include the determination of the following: clinical crown length (gingival margin to incisal edge), anatomic crown length (CEJ to incisal edge), width of keratinized gingiva (mucogingival junction to free gingival margin), location of alveolar crest, tooth position, and frenum 13 involvement. Periapical radiographs of the teeth involved in the treatment are necessary. Etiologies of gummy smile : Many studies have stated the main causes of excessive gingival display, presenting the most important factors which may lead to having a Gummy Smile. The study of Roe et al., [48], described that lip length and the upper lip mobility rate are the main contributing factors. The previous research of Peck et al.,[49] stated that the exposure of teeth and gingiva de-pends on the integrated effects of a number of variables (in-creased muscle capacity, vertical maxillary excess, greater in-terlabial gap at resting position, and the amount of overjet and overbite). Pausch et al.,[ 50] mentioned that abnormal gingival and maxillary anterior teeth display may take place due to numerous anatomic or functional factors, either hered-itary or inborn. A narrow upper lip, an irregular eruption of teeth, excessive protuberance or vertical maxillary growth, and hypermobility of the maxillary lip and elevator muscle are common reasons for a Gummy Smile. In fact, several contributing factors are affecting individuals to have a Gummy Smile. Sometimes one of them is presented, although in some cases more than only one cause can be seen. Correct diagnosis of the reason leads to a proper treat-ment plan. The most common and discussed factors associat-ed with Gummy Smile are: Altered passive eruption : 14 Also known as impaired passive eruption, [ 51] is defined as a condition in which the relationship between teeth, alveolar bone in the maxilla, and the soft tissues displays an excessive gingiva. This, in turn, reveals the clinical characteristic of Gummy Smile[52]. In other words, altered passive eruption (APE) is characterized by excessive gingival exposure in rela-tion to the crowns of the maxillary teeth.[53] in this case, the gingiva fails to migrate in the apical direction during the eruption of teeth, thus, it remains in a coronal position in re-lation with the cementoenamel junction (CEJ), which results in having an unacceptable gingival exposure and unfavor-able small size of the teeth when smiling . [54] Miskinyar et al.[55] ,found that the prevalence of this condition is about 12% of the population. Altered passive eruption was first identified by the study of Coslet et al.[56] ,and according to Rossi et al.,[52] it was classified into two types and two sub-types (Fig 1), 1. Type I : the vertical length of keratinized gingiva is greater than normal, the mucogingival junction (MGJ) is located in an apical position to the level of the cementoenamel junction (CEJ), and clinical crowns appear shorter. 2. TypeII:theverticaldimensionofthekeratinized gingiva is normal, the mucogingival junction is positioned at the lev-el of the CEJ. 2.1 Subtype A : the measurement between the maxillary alve-olar crest and the CEJ is around 1.5 mm, and in this case a regular attachment can be found. 2.2 Subtype B : the level of maxillary alveolar crest is at the level of the CEJ, or occlusal to the CEJ in some cases. 15 تسمية توضيحية 16 17 18 Bony maxillary excess : This includes vertical maxillary excess and bimaxillary pro-trusion . A. Vertical maxillary excess : Wolford et al., [ 57] defined Maxillary vertical hyperplasia or vertical maxillary excess as an excessive vertical growth of the maxilla which may or may not lead to an anterior open bite. In his study Robbins [ 58] explained that to make the correct diagnosis, the face must be divided into three equal thirds or parts for the critical evaluation of the height of the face. Vertical maxillary excess is noticed when the length of the lower third of the face is more than the other two thirds, causing an excessive gingival display. [ 59] In the analysis of the face, vertical maxillary excess has the following features: longer lower third of the face, in relation with the upper and middle thirds, a greater display of maxillary incisors at rest, an incompetent lip, inclination towards class II malocclusion with or without open bite, and a noticeable Gummy Smile. The nose is longer as well, the alar bases are small and the zygoma appears to be generally flat. The lower third of the face is long, leading to a retrognathic shape of the jaw [60] .Furthermore, the incisal edge of the upper anterior teeth might be covered by the lower lip because of the extravagant downward growth of the maxilla . [61] Peck et al., [62] and Mackley [63] found that a Gummy Smile is highly related to anterior vertical maxillary excess (about 2-3 mm). Moreover, Ezquerra and Berrazueta [64] discuss that excessive maxilla 19 associated with the protrusion of anterior alveolar bone con-sequently produce a Gummy Smile. Whilst Wu et al., [65] in their study also stated that anterior maxillary height (upper incisor to the palatal plane) was considerably more in both male (+1.03 mm) and female (+2.13 mm) groups who have Gummy Smile. B. Bimaxillary protrusion : Bimaxillary protrusion is a frequently diagnosed deformity in African Americans [66] ,and Asian populations as well. This deformity is described regarding the protrusive and buccally positioned maxillary and mandibular incisors, as well as the enlarged prostration of the lips. It can be found with an incompetent lip, excessive gingival display, mentalis strain with an anterior open bite. Bimaxillary protrusion refers to an abnormally protruded maxillary and mandibular dentoalveolus. Generally, this presents with malocclusion and dentoalveolar flaring of both the maxillary and mandibular anterior teeth, which cause the lips to be protruded, thus, producing an additional convexity of the facial profile. Bimaxillary protrusion is mainly accompanied by several degrees of lip deficiency (de- 20 fined as more than 4 mm of lip detachment at the rest state). The tendency of the anteroposterior correlation is to be a class II malocclu- sion with a de- ficient mandible, al- though it may also range from class severe II to class III. [67] The etiology behind bimaxillary protrusion is associated with various reasons between genetics and environment, such as mouth breathing, lip biting habit and large size of the tongue. [68] Keating et al., [69] discovered that in Caucasians with bimaxillary protrusion, it is likely to notice a posterior cranial base which is shorter than normal, a prognathic maxilla with vertical excess, mild class II skeletal occlusion, and a prostrate profile. Conditions causing gingival enlargement : Gingival enlargement might be the outcome of bacterial plaque-enhanced chronic inflammation and medications.[54] 21 Narwal et al., [70] showed in their case report an abnormal unilateral palatal soft tissue enlargement in a 61-year-old hypertensive female using amlodipine, which is a safe antihypertensive drug. Ritchhart et al., [71] stated a process behind uncontrolled cell proliferation in drug- induced gingival overgrowth which is the suppression of apoptotic pathways, with the following effect on the normal gingival formation by cell turnover. Hormonal differences which take place in pregnancy and puberty, in addition to the use of oral contraceptives have been associated with gingival overgrowth.[54] other effects such as age, demographic and pharmacokinetic changes, genetic predisposition, oral hygiene condition, as well as molecular and cellular variables may impact the mechanism of gingival enlargement. [71, ,72] Orthodontic treatment using orthodontic appliances can also participate in the presence of gingival enlargement. [73] In the case of leukemia, leukemic cells might infiltrate to the gingiva,[74] and this will cause some manifestations to be present such as gingival enlargement and bleeding.[75] 22 Short upper lip : The upper lip length is defined as the length from the base of the nose (subnasale point) to the inferior part of the upper lip (upper lip stomion point),[48] which is normally around 23 mm in males and 20 mm in females[76] . If an individual with excessive gingival display has a short upper lip as well, the esthetic compromise will be affected.[58] The diagnosis of an excessive gingival display can be done regarding the clinical measurement of the upper lip length with an exces-sive amount of tooth display at rest.[54] Conversely, Roe et al., [48] found in their study that in maximum smile, there is no notable difference in the gingival display between an in- 23 dividual with a short or normal upper lip, and they conclud-ed that the association of some factors such as higher muscle capacity, vertical maxillary excess, excessive interlabial gap at rest, and the amount of overjet and overbite have a greater effect on the gingival display than the upper lip length itself. Moreover, Sarver et al., [77] explained that what is crucial is the correspondence between the upper lip length, the maxilliary incisors, and the commissure of the mouth. In other words, the lip length should be almost equal to the commis- sure of the mouth. Hypermobility of the upper lip : In the case of normal face height, gingival levels, lip length and length of central incisors in a patient who has an excessive gingival display, the possible etiology is hypermobility of the maxillary upper lip.[58] Upper lip mobility was ex-plained as the volume of lip movement that exists when an individual smiles. This was measured by deducting the in-cisal shown at rest from the dentogingival display during a full smile. [48] Hypermobility of the upper lip is associated with a hyper function of the lip elevator muscles and basical-ly leads to excessive gingival display.[ 64] Peck and Peck [ 78] reported an average lip movement of 5.2 mm (23% decrease) from a measured lip length of 22.3 mm during a full smile. Furthermore, in a study evaluating spontaneous smiles, 24 Tarantili et al., [ 79] identified a 28% decrease in the initial upper lip length, while Roe et al., [48] concluded the overall means of lip mobility for females with normal lip length, females with short lip length, males with normal lip length and males with short lip length were 5.8 ± 1.7 mm, 5.0 ± 1.3 mm, 6.7 ± 1.5 mm, and 5.7 ± 1.1 mm, respectively. Moreover, Sabri et al., [76] stated that in smiling, the upper lip is elevat-ed by about 80% of its original length. Bhola et al.[54] as well as Robbins[48] stated that the upper lip is generally elevated around 6-8 mm from the rest position to the position reached when a full smile takes place. Treatment of gummy smile : Excessive gingival display can be managed by a variety of procedures. These procedures include non- surgical and surgical methods. The underlying cause of excessive gingival display or Gummy Smile has the main effect on the type of procedure that will be performed. [80] Non-surgical procedures may include Botulinum toxin type A injection as well as orthodontics, While surgical procedures might include lip repositioning or orthognathic surgery following orthodontics. A.Surgical procedures : In the case of altered passive eruption : a higher amount will exist, and the treatment of choice is normally gingivectomy following by aesthetic crown lengthening to attain the desired dimension and morphology of 25 teeth. However, when the diagnosis shows bone levels close to the CEJ, a gingival flap with ostectomy is performed, or what is also known as an apically positioned flap. [81] Orthodontic eruption or intrusion can also be done when hav-ing gingival asymmetry on one or multiple anterior teeth[81] . In the case of vertical maxillary excess : the only treatment option to consider is orthognathic surgery. [82] This is applied to impact the maxilla considering the amount of gingival exposure diagnosed. Maxillary impaction allows correction of the Gummy Smile, long face syndrome, specific types of open bite from a skeletal origin and labial sealing. [83] The Le Fort I osteotomy of the maxilla allows re-duction of bone between the nasal floor and apices of maxil-lary teeth which permits superior repositioning (impaction) of the maxilla. [59] In the case of the bimaxillary protrusion : the treatment option may be composed of first premolar extractions followed by the osteotomy through the extraction sites to mobilize the anterior segment of the maxilla. The aim is to setback the segment in addition to lessening the labial flaring of the incisors. Maxillary setback alone can sometimes provide a substitute for the treatment of anterioposterior maxillary excess without any need for tooth extraction or segmental osteotomy in these cases: 26 (1) it is contraindicated to perform extractions in an ortho-dontic diagnosis (no dental crowning, adequate curve of Spee, etc.) (2) the proclination of maxillary incisors can be adjusted to an acceptable position with a Le Fort I osteotomy in addition to clockwise rotation. [67] In the case of excessive gingival display resulted from short upper lip and/or hypermobility of the upper lip : a surgical procedure known as lip repositioning surgery is preferred for a minimally invasive surgery. It is composed of an oval mucosal excision followed by coronally advanced flap. This procedure is done to reduce the hyperactivity of the elevator muscles and reform the depth of the vestibule[84] . It was first described by Rubinstein and Kostianovsky [ 85] and the aim was the treatment of excessive gingival display associated with hypermobility of the lip, and was then modified by Litton and Fournier[86] to include also the treatment of Gummy Smile caused by short upper lip, by separating the muscles from the underlying bony structures to place the upper lip in a coronal position. This surgical procedure was accompanied with no complications, although there were some incidences of relapse, [87] consequently, some attempts were done to improve it by Miskinyar. [88] Recently, Bhola et al.,[ 54] described a technique similar to the one which was described by the article of Rubinstein and Kostianovsky under the name of Lip Stabilization Technique (LipStaT). 27 The only obvious difference between the two techniques is that in LipStaT, a vertical incision is done posteriorly to connect the inferior incision (at the mucogingival junction) and the superior incision (into the vestibule). The ratio of this incision is the height being double of gingival expo-sure during a full smile. While in Rubinstein and Kos-tianovsky technique, the two incisions were approximated till they meet posteriorly. In the case of the presence of external factors causing gingival overgrowth : the treatment plan should be focused on the exact cause of the enlarged gingiva. Meticulous history taking, in addition to an excisional/incisional biopsy and/ or hematologic/histo-logic inspection might be performed generally to make the correct diagnosis of the uncommon conditions of gingival enlargement. Plaque control is an important aspect of treatment 28 in all the patients. Some of these cases may resolve when the external element that is inducing the gingival enlargement is adjusted or suspended, For example, gingival overgrowth during pregnancy and puberty might need the elimination of all local irritants followed by surgical treatment for the re-moval of any fibrotic residuals.[89] B. Non surgical procedures : the injection of Botulinum toxin type A which has been suggested for treatment of hypermobility of the upper lip, but this may only provide temporary advantages. [90] Another way to fix a gummy smile is by using dermal fillers or lip fillers. By injecting your lips with a dermal filler, we can plump up your upper lips and reduce the amount of gum shown. 29 Botox : Botox is the trade name for the neurotoxin protein botulinum toxin type A produced by fermentation of anaerobic bacterium clostridium botulinum. Type A is one of the seven distinct botulinum toxins produced by different strains of the bacterium. It is a stable, sterile, vacuum-dried powder that is diluted with saline solution without preservatives for it to be injected. 30 The total "dose" of Botox in each vial is always 100 units but different amounts of saline solution can be used with each vial depending on the intended use Each vial of BOTOX contains : 1. 100 Units (U) of Clostridium botulinum type A neurotoxin complex, 2. 0.5 milligrams of Albumin Human, 3. And 0.9 milligrams of sodium chloride in a sterile, vacuum-dried form without a preservative. A brief history of botox : Over the last two decades, BOTOX has been approved by the Food and Drug Administration (FDA) for therapeutic treatments of eye muscle problems (in1989), neck problems (in 2000), and excessive sweating (in 2004). At present, it is being investigated for treating other medical conditions. In 2002, the FDA approved Allergen’s BOTOX Cosmetic for the pur-pose of temporarily erasing facial lines[91,92&93 ] . Mechanism of Action : BOTOX decreases muscle activity by blocking overactive nerve impulses that trigger excessive muscle contractions or glandular activity . Phase I. Nerve-Muscle Communication is blocked : BOTOX blocks the transmission of overactive nerve impulses to the targeted muscle by selectively preventing the release of the neurotransmitter acetylcholine (ACh) at the neuromuscu- 31 lar junction, temporarily preventing muscle contraction. This is primarily a local effect. BOTOX may also prevent the release of pain-stimulating neuropeptides in peripheral nerves. A) Binding : The heavy chain portion of the active ingredient in BOTOX binds to the cell membrane of the motor nerve via an unidentified high-affinity “acceptor” molecule. This high-affinity binding action allows for efficient uptake of BOTOX® by the motor nerve and facilitates selective, targeted treatment at the injection site. B) Internalizing : After binding, the BOTOX protein molecule passes through the cell membrane of the motor nerve and into its cytoplasm via a process called endocytosis. It is here that the enzymatic component (light chain) of the BOTOX protein molecule is activated. 32 C) Blocking : Inside the motor nerve, the light chain of the BOTOX protein molecule cleaves apart a protein (called SNAP25) that enables vesicles which store the neurotransmitter acetylcholine to attach to the cell membrane. Cleaving SNAP25 prevents these vesicles from fusing with the membrane and prevents the release of acetylcholine into the neuromuscular junction (the space between the motor nerve and the muscle). Thus, nerve impulses that control muscle contractions are blocked decreasing muscle activity. Cleaving SNAP25 also blocks release of neuropeptides involved in the transmission of painful sensations (including substance P, glutamate and cal-citonin gene-related peptide, or CGRP), theoretically reduc-ing pain sensitization of peripheral nerves. This may be how BOTOX reduces the neck pain associated with cervical dys-tonia, although the exact mechanism of action is unknown. Phase II. Nerve-Muscle Communication is restored : The effect of BOTOX is generally temporary. Previous nerve impulse activity and associated muscle contractions resume over the course of a few to several months, depending on the 33 individual patient and the indication for which they are being treated. A. Nerve Sprouting : New nerve endings sprout and connect to the muscle after the original nerve ending is blocked, renewing the ability of the nerve to cause muscle contractions. B) Original Nerve Connection Re- established : Eventually, the new nerve sprouts retract and the original nerve ending regains its function, suggesting that treatment with BOTOX does not permanently alter the neuromuscular junction. Indication : 34 1. Strabismus 2. Cervical dystonia, 3. Blepharospasmand 4. Hemifacialspasm, 5. Hyperfunctionallarynx, 6. Juvenile cerebral palsy 7. Spasticity 8. Pain and headache 9. Occupational dystonia and writer.s cramp, Uses of botox in dentistry : 1. Tempromandibular disorders 2. Massetric hypertrophy 3. Hemifacial spasm 4. Myofacial pain 5. Bruxism 6. Trismus, sialorrhea 7. Retraining muscles during orthodontic therapy, in patients with a very strong musculature. 8. Training the patient to get used to new dentures, especially in patients with strong irregular muscle contractions, who have been edentulous for a long time and have old dentures and they are significantly over closed. 9. Jaw line contouring by injecting into masseter muscle thus weakening it and some bulk of this muscle is reduced, resulting in a more tapered jaw line. Procedure for injection : For correction of gummy smile, Botox is injected into the hyperactive elevator muscles of lip blocking excessive contrac- 35 tions and thus prevent the lip from being pulled too far up while smiling. It will be important for the patient to avoid taking aspirin or related products, such as ibuprofen (e.g., Advil) or naproxen if possible after the procedure to keep bruis-ing to a minimum. Prior to injection, reconstitute vacuum-dried BOTOX, with sterile normal saline without a preserva-tive; 0.9% Sodium Chloride Injection is the only recommended diluents. Draw up the proper amount of diluents in the appro-priate size syringe, and slowly inject the diluents into the vial. BOTOX should be administered within four hours after recon-stitution. During this time period, reconstituted BOTOX should be stored in a refrigerator (2° to 8°C). Reconstituted BOTOX should be clear, colorless and free of particulate mat- ter. Mario Polo [ 94, 96] has advocated injection of botox at LLS, LLSAN, LLS /ZM overlaps and in severe cases at depressor nasii & OO also. The ideal dosage might be 2.5 U per side at the LLS & LLSAN, 2.5 U per side at the LLS/ZM sites, and 1.25 U per side at the OO sites. 36 Very recently Hwang et al ;[95] Yonsei University College of Dentistry, Seoul, Korea have proposed a injection point for botulinum toxin-A, and named it as YONSEI POINT and they recommend a dose of 3U at each Yonsei Point Yonsei point is located at the centre of the triangle formed by : 1. levator labii superioris [LLS], 2. levator labii superioris alaeque nasi [LLSAN], 37 3. and zygomaticus minor [Zmi]. How often do patients need to return for addi-tional injections ? Effect of Botox is seen within 5-10 days and lasts about 6 months, with a range of 4 to 8 months, at which time the patient can return to repeat the process. It is important not to give injections prematurely (before the effects of the treatment have worn off), as this can result in a buildup of antibodies to Botox that would dilute the effect of further treatments. Contraindications : 1. During pregnancy or while breast feeding 2. Presence of inflammation or infection at the site of proposed injection 3. Anyone with known hypersensitivity or allergies to human albumin, Botox toxin, or saline solution. 4. Anyone with known motor neuropathy, neuromuscular disorders such as amyotrophic lateral sclerosis, myasthenia 38 gravis, Lambert-Eaton Syndrome, muscular dystrophy, multi-ple sclerosis etc. 5. Anyone taking Aminoglycoside antibiotics because amino-glycosides may interfere with neuromuscular transmission and potentiate the effect of Botox therapy. 6. Anyone taking Calcium Channel Blockers. Side effects : 1. Nausea 2. Localized pain 3. Infection 4. Inflammation 5. Tenderness 6. Swelling 7. Redness, and/or 8. Bleeding/bruising Disadvantages : 1. Short term effect 2. Asymmetrical/unnatural appearance of smile sometimes due to improper injection technique 3. Cost factor Advantage : 1. Psychological benefit to the patient 2. Minimally invasive 39 Filler : The perioral region is the framework through which the teeth appear [97]. Well- defined and full lips give a youthful and attractive appearance .[97] A variety of absorbing and permanent fillers were used to shape the lips [ 98]. In recent years[ 97,98] , the fillers derived from hyaluronic acid have become the most effective medium to correct soft tissues, and the best filler for lips augmentation[99] . there are two essential points to observe: the first is the shape of the lips and the second is their relationship with the other parts in the lower third of the face, especially the support provided by the bone struc-tures and teeth [100]. Lip augmentation includes the reshaping and / or increasing the size of the visible part of the lips, the vermilion, changing the shape of the Cupid’s bow and the relationship between the vermilion and the skin below the columella of the nose, all of which is considered within lip filling [98] . The lips augmentation can be done using either surgical or injection procedures to increase the size and obtain well-de-fined borders of the lips[ 101] . Fillers are products that are in-jected into soft tissues to increase volume, correct defects, fill wrinkles, and shape the face. Fillers are classified into : 40 absorbent and non-absorbent (permanent) materials, and may also be classified according to the injection site (within the dermis or under the skin), to the source of the material (autogenous, animal, industrial, semi-industrial) or to the duration of its effect (temporary: less than six months, long-term: from six months to two years, semi- permanent: two to five years, permanent: more than five years) [102] . Today, hyaluronic acid is commonly used to fill the lips due to its hydrophilic proper-ties and the natural appearance that it gives. Its effect lasts be-tween 3 and 6 months and can continue in some patients for extended periods of time . [103] Mercado-Rosso classification of gummy smile : According to the Mercado-Rosso classification, gummy smile is divided into three different types: Type 1, char- acterized by a lack of support and/or a lack of projection of the upper maxilla. This type is defined by a thin white lip, associated with the presence of perioral wrinkles (barcode). Type 2, character-ized by a deep pyriform fossa, thickness of the upper lip is slightly greater, fewer skinfolds and wrinkles, and a higher lip elevation at the areas of the 12th and 13th, as well as 22th and 23th dental pieces due to an imbalance between the strength (excess) of the levator muscles and the resistance (defect) of the soft tissue. Finally, the type 3 is defined by an excessive strength of the zygomatic muscles, which causes a wide smile and an excessive . 41 Treatment approach of gummy smile with hyaluronic acid fillers according to the Mercado-Rosso classification : The therapeutic approach proposed is based on the concept of RD Dynamic Restructuring . RD Dynamic Restructuring makes reference to the action of the HA fillers on the muscle movement, looking for balance between the muscle activity and different facial structures (bone, superficial musculoaponeurotic system, subcutaneous cellular tissue, and skin), by stretching the ligaments or increasing the resistance of the soft tissues to be folded. 42 Treatment of gummy smile type 1 : As aforementioned, according to the Mercado-Rosso clas- sifi-cation, the gummy smile Type 1 is characterized by a lack of structural support. In this type of gummy smile the treatment strategy is: • Administration system Blunt microcannula (25G and 50 mm). • Hyaluronic acid 23 mg/mL. • Depth Deep Supramuscular and/or in a multilayer approach. • Total amount 0.6 mL of HA per side, distributed in 12 retro-grade injections (0.05 mL per application) per side. • Treated area The whole white lip, from the entrance to piriformis fossa to the midline. At approximately 5 mm of the corner of the mouth, by means a blunt microcannula (25G and 50 mm), with a retrograde fanning technique from the entry point to the piriformis fossa to the midline, 0.6 ml of HA (23 mg/mL) is injected at a supramuscular plane. The purpose is to act on the entire white lip, with the objective of providing (and/or recovering in those cases with aging changes) structural support. The objective is cor- 43 recting the projection deficit and to increase the resistance of the white lip to be folded. In those cases, with a major lack of projection of the anterior nasal spine and/or premaxilla deficiency, it would be necessary to inject an additional bolus of HA (23 mg/ ml) (Teosyal RHA4, Teoxane, Geneve, Switzerland) in the premaxilla area, at the projection of the anterior nasal spine at the supraperiostium level . In other cases, upon reaching the central region of the white lip, it would be preferable to leave small boluses at the end of each fanning retrograde administration (circumscribed to the edges of the insertion of the nasal wings). Lower image: The recommended : strategy is 0.6 ml/per side of high-density hyaluronic acid (HA) filler (RHA4Ò, Teoxane, Geneve, Switzerland) administered by means fanning retrograde technique with a blunt microcannula. Additionally, small boluses (blue ellipses) 0.4 mL–0.6 mL de HA 23 mg/mL at 44 the end of each fanning retrograde administration upon reach-ing the central region of the white lip and circumscribed to the edges of the insertion of the nasal wings. a Frontal view. b lat-eral view Treatment of gummy smile type 2 : The type 2 gummy smile is mainly defined by an unbalanced activity of the levator muscles. The recommended treatment strategy is: • Administration system: Blunt microcannula (25G and 50 mm). Hyaluronic acid: 23 mg/mL. • Depth: Supramuscular /intramuscular • Total amount: • A total of 0.2–0.4 mL of HA per side at the piriformis fossa. • A total of 0.2 mL per side at the levator labii superioris alaeque nasi. • A total of 0.1 mL per side at the anterior nasal spine. • Patient, can also have type 1 in these cases: • Treated area Piriformis fossa (looking for the Levator labii superioris muscle). The injection is administered at approximately 5 mm of the corner of the mouth, by means a blunt microcannula (25G and 50 mm), with a fanning technique and looking, at the piri-formis fossa, for a deep plane superficial to levator labii supe-rioris. It is recommended, before to start the HA administra-tion, that the patient gesticulates for determining the blunt shifting. Once the levator labii superioris muscle has been loca- ted, we proceed to inject a bolus of 0.2 to 0.4 mL of a 45 crosslinked HA filler (23 mg/mL), with the goal of modulate the muscle activity. As a second step, the canula should be medial-ly slide, looking for a parallel point, almost under the nasal wing insertion, which allows to limit the strength of contrac-tion of the levator labii supe rioris alaeque nasi. At this point, approximately 0.1 mL of 23 mg/ml HA filler should be injected. Finally, sliding the blunt micro- cannula to the nasal spine, but without touching it, 0.2 mL of 23 mg/ml HA filler needs to be placed on the depressor septi nasi muscle Once the effect of RD Dynamic Restructuring on the gingival smile has been observed, it is time to proceed to treat the un-derlying Type 1 gummy smile, as appropriate. Treatment of gummy smile type 3 : There is an overactivity of the zygomatic muscles. The recom-mended treatment strategy is: Administration system: Needle (27G and 30 mm). Hyaluronic acid: 25 mg/mL. Depth: Periosteum. Total amount: 0.4 mL–0.8 mL of HA per side, distributed in 2 boluses (0.2 mL–0.4 mL/per bolus/per side). 46 Treated area: Malar region. Patient, can also have type 1 o 2 characteristics, 47 References 1 Vig RG, Brundo GC. The kinetics of anterior tooth display. J Prosthet 2 Dent 1978;39:502-4. Peck S, Peck L, Kataja M. Some vertical lineaments of lip position. Am J Orthod 3 Dentofacial Orthop 1992;101:519-24. Tjan AH, Miller GD. The JG. Some esthetic factors in a smile. J Prosthet Dent 1984;51:24-8. 4 Jensen J, Joss A, Lang NP. The smile line of different ethnic groups in relation to age and gender. Acta Med Dent Healv 1999;4:38-46. 5 Liébart MF, Fouque-Deruelle D, Santini A, Laurent F, Monnet- Corti V, Jean-Marc G, et al. Smile line and periodontium 6 visibility. J Periodontal Res 2004;1:17-25. Monaco A, Streni O, Marci MC, Marzo G, Gatto R, Giannoni M. Gummy smile: Clinical parameters useful for diagnosis and therapeutical approach. J Clin Pediatr Dent 2004;29:19-25 48 7 Reddy PK, Nayak DG, Uppoor A. Aesthetic crown lengthening: A report 8 9 10 11 of 3 cases. Malay Dent J 2006;1:110-3. Hwang WS, Hur MS, Hu KS, Song WC, Koh KS, Baik HS, et al. Surface anatomy of the lip elevator muscles for the treatment of gummy smile using botulinum toxin. Angle Orthod 2009;79:70-7. Kim TW, Kim H, Lee SJ. Correction of deep overbite and gummy smile by using a mini-implant with a segmented wire in a growing Class II Division 2 patient. Am J Orthod Dentofacial Lin JC, Yeh CL, Liou EJ, Bowman SJ. Treatment of skeletal- Lin JC, Yeh CL, Liou EJ, Bowman SJ. Treatment of skeletal- Lin JC, Yeh CL, Liou EJ, Bowman SJ. Treatment of skeletalPassia N, Blatz M, Strub JR (2011) Is the smile line a valid parameter for esthetic evaluation? a systematic literature 12 review. Eur J Esthet Dent 6(3):314–327 Beall AE (2007) Can a new smile make you look more intelligent and successful? Dent Clin North Am 51(2):289–297 49 13 Ker AJ, Chan R, Fields HW, Beck M, Rosenstiel S (2008) Esthetics and smile characteristics from the layperson’s perspective: a computer-based survey study. 14 15 J Am Dent Assoc 139(10):1318–1327 Tjan AH, Miller GD, The JG. Some esthetic factors in a smile. J Prosthet Dent 1984;51(1):24–8 Rigsbee OH 3rd, Sperry TP, BeGole EA. The influence of facial animation on smile characteristics. Int J Adult Orthodon 16 Orthognath Surg 1988;3(4):233–9. Peck S, Peck L, Kataja M. Some vertical lineaments of lip position. Am J Orthod 17 Dentofacial Orthop 1992;101(6):519–24. Maulik C, Nanda R. Dynamic smile analysis in young adults. Am J Orthod 18 19 Dento- facial Orthop 2007;132(3):307–15. Miron H, Calderon S, Allon D. Upper lip changes and gingival exposure on smil-ing: vertical dimension analysis. Am J Orthod Dentofacial Orthop 2012;141(1): 87–93 Han SH, Lee EH, Cho JH, et al. Evaluation of the relationship between upper incisor exposure and cephalometric variables in Korean young adults. Korean J Orthod 2013;43(5):225–34. 50 20 Zhang YL, Le D, Hu WJ, et al. Assessment of dynamic smile and gingival contour in young Chinese 21 22 people. Int Dent J 2015;65(4):182–7. Awad MA, Alghamdi DS, Alghamdi AT. Visible portion of anterior teeth at rest and analysis of different smile characteristics in the Saudi Population of the Jeddah Region. Int J Dent 2020;2020:8859376. Hunt O, Johnston C, Hepper P, et al. The influence of maxillary gingival exposure on dental attractiveness ratings. Eur J 23 24 25 Orthod 2002;24(2):199–204. Geron S, Atalia W. Influence of sex on the perception of oral and smile esthetics with different gingival display and incisal plane inclination. Angle Orthod 2005; 75(5):778–84. Kokich VO, Kokich VG, Kiyak HA. Perceptions of dental professionals and layper- sons to altered dental esthetics: asymmetric and symmetric situations. Am J Or- thod Dentofacial Orthop 2006;130(2):141–51. Ker AJ, Chan R, Fields HW, et al. Esthetics and smile characteristics from the lay- person’s perspective: a computer-based survey study. J Am Dent Assoc 2008; 139(10):1318–27. 51 26 Ioi H, Nakata S, Counts AL. Influence of gingival display on smile aesthetics in 27 Japanese. Eur J Orthod 2010;32(6):633–7. Micheli-Pellegrini V (2011) About muscle insertions in man (Proposal for a new nomenclature of striated muscle). Acta 28 29 Otorhinolaryngol Ital 31(3):167–176 von Arx T, Nakashima MJ, Lozanoff S (2018) The face – a musculoskeletal perspective. A Lit Rev Swiss Dent J 128(9):678–688 Hur MS, Hu KS, Park JT, Youn KH, Kim HJ (2010) New anatomical insight of the levator labii superioris alaeque nasi and the transverse part of the nasalis. Surg 30 Radiol Anat 32(8):753–756 Hur MS, Youn KH, Hu KS, Song WC, Koh KS, Fontaine C, Kim HJ (2010) New anatomic considerations on the levator labii superioris related with the nasal 31 ala. J Craniofac Surg 21(1):258–260 Olszewski R, Liu Y, Duprez T, Xu TM, Reychler H (2009) Three-dimensional appearance of the lips muscles with three-dimensional isotropic MRI: in vivo study. Int J Comput Assist Radiol Surg 4(4):349– 352 52 32 Ackerman MB, Ackerman JL (2002) Smile analysis and design in the digital era. J Clin Orthod 36(4):221–236 Ackerman MB, Ackerman JL (2002) Smile analysis and design in the digital era. J Clin Orthod 36(4):221–236 Ackerman MB, Ackerman JL (2002) Smile analysis and design in the 33 34 35 digital era. J Clin Orthod 36(4):221–236 Peck S, Peck L, Kataja M (1992) The gingival smile line. Angle Orthod 62(2):91–100 Peck S, Peck L (1995) Selected aspects of the art and science of facial esthetics. Semin Orthod 1(2):105–126 Arnett GW, Bergman RT (1993) Facial keys to orthodontic diagnosis and treatment planning. Part I Am J Orthod 36 Dentofacial Orthop 103(4):299–312 Jacobs PJ, Jacobs BP (2013) Lip repositioning with reversible trial for the management of excessive gingival display: a case series. Int J Periodontics 37 Restorative Dent 33(2):169–175 Geron S, Atalia W (2005) Influence of sex on the perception of oral and smile esthetics with different gingival display and incisal plane inclination. Angle Orthod 75:778–784 53 38 Flores-Mir C, Silva E, Barriga MI, Lagravere MO, Major PW (2004) Lay person’s perception of smile aesthetics in dental and facial views. J Orthod 31(3):204–209 39 Kokich VO Jr, Kiyak HA, Shapiro PA (1999) Comparing the perception of dentists and lay people to altered dental esthetics. J Esthet Dent 11:311–324 40. Ioi H, Nakata S, Counts AL (2010) Influence of gingival display on smile aesthetics in Japanese. Eur J Orthod 32:633–637 40 Ioi H, Nakata S, Counts AL (2010) Influence of gingival display on smile aesthetics in Japanese. Eur J Orthod 32:633–637 41 Armitage GC (1999) Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4(1):1–6 42 Dong JK, Jin TH, Cho HW, Oh SC (1999) The esthetics of the smile: a review of some recent studies. Int J Prosthodont 12(1):9–19 54 43 Tjan AH, Miller GD, The JG (1984) Some esthetic factors in a smile. J 44 45 46 Prosthet Dent 51:24–28 Rubin LR (1974) The anatomy of a smile: its importance in the treatment of facial paralysis. Plast Reconstr Surg 53(4):384– 387 London ̃o MA, Botero P (2012) The smile and its dimensions. RevFac Odontol Univ Antioq 23(2):353–365 Pavone AF, Ghassemian M, Verardi S. Gummy smile and short tooth syndrome Part 1: etiopathogenesis, classifica- tion, and diagnostic guidelines. Compend Contin Educ Dent 2016; 37(2): 102-7. 57 Dym H, Pierre R 2nd. Diagnosis and Treatment Approaches to a "Gummy Smile". Dent Clin North Am. 2020; 48 64(2): 341-49. Roe P, Rungcharassaeng K, Kan JYK, Patel RD, Campagni WV, Brudvik JS. The Influence of Upper Lip Length and Lip Mobility on Maxillary Incisal Exposure. Am J Esthet Dent 2012;2:116- 125. 49 Peck S, Peck L, Kataja M. The gingival smile line. Angle Orthod 1992;62:91-100. 55 50 Pausch NC, Katsoulis D. Genderspecific evaluation of variation of maxillary exposure when smiling. J 51 Craniomaxillofac Surg 2017;45:913-20. Izraelewicz-Djebali E, Chabre C. Gummy smile: orthodontic or surgical treatment? Dentofacial Anom Orthod 2015;18:102. Published online: 04 September 2015. 52 Rossi R, Brunelli G, Piras V, Pilloni A. Altered passive eruption and familial trait: a preliminary investigation. Int J 53 Dent 2014; 2014:874092. SCS, Higashi C, Bonafé E, Pilatti GL, Santos FA, Tonetto MR, et al. Crown Lengthening as Treatment for Altered Passive Eruption: Review and Case 54 Report. World J Dent 2015;6:178- 83. M, Fairbairn PJ, Kolhatkar S, Chu SJ, Morris T, de Campos M. LipStaT: The Lip Stabilization Technique- Indications and Guidelines for Case Selection and Classification of Excessive Gingival Display. Int J Periodontics Restorative 55 Dent 2015;35: 549-59. Miskinyar SA. A new method for correcting a gummy smile. Plast Reconstr Surg 1983;72:397-400. 56 56 Coslet JG, Vanarsdall R, Weisgold A. Diagnosis and classification of delayed passive eruption of the dentogingival junction in the adult. 57 58 59 Alpha Omegan 1977;7:24-8. Wolford LM, Karras SC, Mehra P.Considerations for orthognathic surgery during growth, part 2: maxillary deformities. Am J Orthod Dentofacial Orthop 2001;119:102-5. Robbins JW.Differential diagnosis and treatment of excess gingival display. Pract Periodontics Aesthet Dent 1999;11:265- 72 Bhola M, Fairbairn PJ, Kolhatkar S, Chu SJ, Morris T, de Campos M. LipStaT: The Lip Stabilization Technique- Indications and Guidelines for Case Selection and Classification of Excessive Gingival Display. Int J Periodontics Restorative 60 Dent 2015;35: 549-59. andibular self- Nascimento Meger M, Tiboni F, dos Santos FS, Verbicaro T, Deliberador TM, Scariot R, et al. Surgical correction of vertical maxillary 61 excess associated with mandibular Robbins JW.Differential diagnosis and treatment of excess gingival display. Pract Periodontics Aesthet Dent 1999;11:265- 72. 57 62 63 Peck S, Peck L, Kataja M. The gingival smile line. Angle Orthod 1992;62:91-100. Mackley RJ. An evaluation of smiles before and after orthodontic treatment. 64 65 Angle Orthod 1993;63:183-90. Ezquerra F, Berrazueta MJ, RuizCapillas A, Arregui JS. New approach to the gummy smile. Plast Reconstr Surg 1999;104:1143-50. Wu H, Lin J, Zhou L, Bai D. Classification and craniofacial features of gummy smile in adolescents. J Craniofac Surg 66 2010;21:1474-9. Scott SH, Johnston LE. The perceived impact of extraction. and Scott SH, Johnston LE. The perceived impact of extraction. and Scott SH, Johnston LE. 67 68 69 The perceived impact of extraction. and Chu YM, Bergeron L, Chen YR. Bimaxillary protrusion: an overview of the surgical-orthodontic treatment. Semin Plast Surg 2009;23:32-9. Lamberton CM, Reichart PA, Triratananimit P. Bimaxillary protrusion as a pathologic problem in the Thai. Am J Orthod 1980;77:320-9. Keating PJ. Bimaxillary protrusion in the Caucasian: a cephalometric study of the morphological features. Br J Orthod 1985;12:193- 201. 58 70 Narwal A, Singh V, Bala S. Drug-induced atypical hyperplasia enveloping salivary gland malignancy. J Indian Soc Periodontol 2017;21:409-11 71 Ritchhart C, Joy A. Reversal of druginduced gingival overgrowth by UVmediated apoptosis of gingival fibroblasts - an in vitro study. Ann Anat 72 73 2018;217:7-11. Nakib N, Ashrafi SS. Druginduced gingival overgrowth. Dis Mon 2011;57:225-30 Trossello VK, Gianelly AA. Orthodontic treatment and periodontal status. J 74 Periodontol 1979;50:665-71. M, Talpaz M. Chronic myeloid leukemia: changing the treatment paradigms. Oncology (Williston Park) 2006;20: 75 76 707-11. Chowdhri K, Tandon S, Lamba AK, Faraz F. Leukemic gingival enlargement: A case report and review of literature. J Oral Maxillofac Pathol 2018;22(Suppl 1):S77-S81. Sabri R. The eight components of a balanced smile. J Clin Orthod 2005;39:155-67. 59 77 Sarver DM, Ackerman MB.Dynamic smile visualization and quantification: Part 2. Smile analysis and treatment strategies. Am J Orthod Dentofacial 78 Orthop 2003;124:116-27. McNamara JA. Jr, Brust EW, Riolo ML. Soft tissue evaluation of individuals with an ideal occlusion and a well-balanced face. In: McNamara JA Jr. (Ed.) Esthetics and the Treatment of Facial Form. Monograph 28. Craniofacial Growth Series. Center for Human Growth and 79 80 Development, Ann Arbor; 1993. Tarantili VV, Halazonetis DJ, Spyropoulos MN.The spontaneous smile in dynamic motion. Am J Orthod Dentofacial Orthop 2005;128:8-15 Abdullah WA, Khalil HS, Alhindi MM, Marzook H. Modifying gummy smile: a minimally invasive approach. J Contemp Dent Pract 2014;15:821-6. 81 Dolt AH 3rd, Robbins JW. Altered passive eruption: an etiology Dolt AH 3rd, Robbins JW. Altered passive eruption: an etiology Dolt AH 3rd, Robbins JW. Altered passive eruption: an etiology 60 82 Pinto SCS, Higashi C, Bonafé E, Pilatti GL, Santos FA, Tonetto MR, et al. Crown Lengthening as Treatment for Altered Passive Eruption: Review and Case 83 84 85 Report. World J Dent 2015;6:178- 83. Steinhäuser S, Richter U, Richter F, Bill J, Rudzki-Janson I. Profile changes following maxillary impaction and autorotation of the mandible. J Orofac Orthop 2008;69:31-41. Humayun N, Kolhatkar S, Souiyas J, Bhola M. Mucosal coronally positioned flap for the management of excessive gingival display in the presence of hypermobility of the upper lip and vertical maxillary excess: a case report. J Periodontol 2010;81:1858-63. Rubinstein AM, Kostianovsky AS. Cosmetic surgery for the Rubinstein AM, Kostianovsky AS. Cosmetic surgery for the Rubinstein AM, Kostianovsky AS. 86 Cosmetic surgery for the Litton C, Fournier P. Simple surgical correction of the gummy Litton C, Fournier P. Simple surgical correction of the gummy Litton C, Fournier P. Simple surgical correction of the gummy 61 87 Grover HS, Gupta A, Luthra S. Lip repositioning surgery: Grover HS, Gupta A, Luthra S. Lip repositioning surgery: Grover HS, Gupta A, Luthra 88 89 90 S. Lip repositioning surgery: Miskinyar SA. A new method for correcting a gummy smile. Plast Reconstr Surg 1983;72:397-400. Agrawal AA. Gingival enlargements: Differential diagnosis Agrawal AA. Gingival enlargements: Differential diagnosis Agrawal AA. Gingival enlargements: Differential diagnosis Polo M. Botulinum toxin type A (Botox) for the neuromuscular Polo M. Botulinum toxin type A (Botox) for the neuromuscular Polo M. Botulinum toxin 91 92 93 type A (Botox) for the neuromuscular Peck S, Peck L, Kataja M. Some vertical linear measurements of lip position. Am J Orthod Dentofac Orthop 1992; 101:519-524. Lowe N J. Botulinum toxin type A for facial rejuvenation: United States and United Kingdom perspectives. Dermatol Surg. 1998. 24: 1216. Binder WJ, Blitzer A, Brin MF. Treatment of hyperfunctional lines of the face with botulinum toxin A Dermatol Surg. 1998; 24:1198-1205. 62 94 Mario polo. Botulinum toxin type A in the treatment of excessive gingival 95 96 97 display; AJO DO 2005; 27(2):214-218. Hwang et al. Surface anatomy of the lip elevator muscles fort he treatment of gummy smile using botulinum toxin.Angle Orthod 2009; 79(1): 70-77. Mario Polo. Botulinum toxin types A (Botox) for the neuromuscular correction of excessive gingival display on smiling (gummy smile) AJO DO 2008; 133(2):195-203. Popenko NA, Tripathi PB, Devcic Z, Karimi K, Osann K, Wong BJ. A quantitative approach to determining the ideal female lip aesthetic and its effect on facial attractiveness. JAMA Facial Plast Surg. 2017; 19(4):261-267. 98 99 Luthra A. Shaping Lips with Fillers. J Cutan Aesthet Surg. 2015; 8(3):139-142. Kablik J, Monheit GD, Yu L, Chang G, Gershkovich J. Comparative physical properties of hyaluronic acid dermal fillers. Dermatol Surg. 2009; 35 Suppl 1:302-312. 63 100 Klein A. The Efficacy of Hyaluronic Acid in the Restoration of Soft Tissue Volume of the Lips and Lower 1/3 of the Face: The Evolution of the Injection Technique. J Chem Dermatol 101 Sci Appl. 2011; 1(4):147-152. Carruthers A, Carruthers J, Hardas B, et al. A validated lip fullness grading scale. 102 103 Dermatol Surg. 2008; 34 Suppl 2:161-166. Chacon AH. Fillers in dermatology: from past to present. Cutis. 2015; 96(5):E17-E19. Lacombe VGK, Theda C. Cosmetic injection techniques - a text and video guide to neurotoxins and fillers. Thieme. 2013:92-93. 64